A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC
A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC
Active, not recruiting · NCT06383052 · Registry updated 2025-05-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC | Metastatic Castration-resistant Prostate Cancer | Active, not recruiting | Phase 1 / Phase 2 | 2025-05-21 | NCT06383052 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Norroy Bioscience Co., LTD | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affliated Hospital of Jiangnan University | Wuxi | China | 1 |